Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review

Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review

Introduction Adjuvant endocrine therapy is a key treatment in oestrogen receptor positive early breast cancer (BC). For premenopausal women, ovarian function suppression (OFS) in combination with either tamoxifen or aromatase inhibitor (AI) is utilised in high-risk cases. The resultant suppression o...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying X. Gue, Dorothy Lau, Alena Shantsila, Gregory Y.H. Lip, Carlo Palmieri
Format: Article
Language:English
Published: Termedia Publishing House 2024-07-01
Series:Archives of Medical Science
Subjects:
tamoxifen
breast cancer
cardiometabolic
aromatase inhibitor
ovarian suppression
Online Access:https://www.archivesofmedicalscience.com/Cardiovascular-and-metabolic-effects-of-ovarian-suppression-in-combination-with-tamoxifen,190743,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.archivesofmedicalscience.com/Cardiovascular-and-metabolic-effects-of-ovarian-suppression-in-combination-with-tamoxifen,190743,0,2.html

Similar Items